Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis

BACKGROUND: Several major randomized control studies have demonstrated that mepolizumab, an anti-IL-5 monoclonal antibody, is effective for patients with severe eosinophilic asthma who show exacerbation or require systemic corticosteroid maintenance therapy. However, the predictive factors of the re...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Pulm Med
Main Authors: Numata, Takanori, Nakayama, Katsutoshi, Utsumi, Hirofumi, Kobayashi, Kenji, Yanagisawa, Haruhiko, Hashimoto, Mitsuo, Minagawa, Shunsuke, Ishikawa, Takeo, Hara, Hiromichi, Araya, Jun, Kuwano, Kazuyoshi
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6790020/
https://ncbi.nlm.nih.gov/pubmed/31606052
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12890-019-0952-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados